Pricing Log in Create free account
Saturday 17 October 2026 Export DGX’s income statement to Excel — free account

Quest Diagnostics Incorporated

DGX Healthcare Diagnostics & Research

Quest Diagnostics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $11.0 billion, up 11.8% from fiscal 2024. In the quarter to June 2026, revenue grew 10.2%, EPS grew 14.7%, free cash flow grew 5.28% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

235.00 4.15 −1.74%
Market cap
$26.4B
P/E
24.6×
Fwd P/E
20.8×
Dividend yield
1.44%
F-score
8/9
Altman Z
3.15
Beneish M
−2.65
Dividend safety
85/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Quest Diagnostics Incorporated (DGX) P/S ratio

Alert me on P/S ratio

As of 16 October 2026, Quest Diagnostics Incorporated (DGX) trades at a P/S ratio of 2.3×. Over the past ten years it has ranged from 1.2× (September 2015) to 2.4× (September 2026); the current reading is higher than 98% of that period. That is below the Diagnostics & Research industry median of 4.4× and below the Healthcare sector median of 3.4×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 1.7× 2.90%
FY2024 1.7× (0.49%)
FY2023 1.7× (6.76%)
FY2022 1.8× (8.80%)
FY2021 2.0× 18.47%
FY2020 1.7× (8.64%)
FY2019 1.9× 23.18%
FY2018 1.5× (17.85%)
FY2017 1.8× 2.02%
FY2016 1.8× 31.23%

Quarterly newest first

Period P/S ratio Change
Jun 2026 2.0× 6.47%
Mar 2026 1.9× 9.51%
Dec 2025 1.7× (11.27%)
Sep 2025 2.0× 2.89%
42 more quarters

Against its own ten years

Low 1.2× High 2.4×
Ten-year median 1.7×
Current reading's percentile 98

P/S ratio against peers

Company P/S ratio
LH Labcorp Holdings Inc. compare 1.8×
DGX Quest Diagnostics Incorporated 2.3×
RVTY Revvity Inc. compare 5.8×
MEDP Medpace Holdings, Inc. compare 6.3×
MTD Mettler-Toledo International, Inc. compare 7.9×
ILMN Illumina, Inc. compare 8.8×
WAT Waters Corporation compare 9.2×
IDXX IDEXX Laboratories, Inc. compare 9.7×
GH Guardant Health, Inc. compare 17.8×
Diagnostics & Research industry median 4.4×
Healthcare sector median 3.4×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on DGX